Delivery Order SPE2DB24D2018-SPE2DB25FWVB7

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a medical product, with a ceiling value of $4,949.76 and a performance period through May 13, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $2,513.52 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $14,793.61 and is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,102.46 and is for the delivery of MULTAQ 400 MG TABLET 60S. The contract is not set aside and has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,248.11 and a performance period through March 26, 2024. The contract is a firm fixed-price, delivery order type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4568508269 MULTAQ 400 MG TABLET 60S, with a ceiling value of $5,770.00 and a period of performance through June 11, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $17,705.55 and a period of performance through February 2025. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,855.08 firm-fixed-price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $24,405.50 and a completion date of June 4, 2025. It is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The award, valued at $30,199.64, has a period of performance through September 18, 2024 and is a firm fixed price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWVB7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $20,482.15 and a performance period ending on June 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/15/25, 9:50 AM